Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 2,872.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 2,872.44% |
Janover Inc Common Stock (JNVR) | 1,426.33% |
Oncology Institute (TOI) | 752.94% |
Protagenic Therapeutics (PTIX) | 520.04% |
Global Interactive Technologies (GITS) | 472.61% |
NETCLASS TECHNOLOGY INC Class A Ordinary Shares (NTCL) | 465.07% |
Dominari (DOMH) | 457.5% |
Regulus Therapeutics (RGLS) | 389.38% |
Yoshiharu Global (YOSH) | 361.82% |
ThredUp (TDUP) | 355.56% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 330.67% |
Oriental Culture Holding (OCG) | 318.49% |
Nutex Health (NUTX) | 314.8% |
CervoMed (CRVO) | 290.83% |
Abits (ABTS) | 290.28% |
Upexi (UPXI) | 225.28% |
QuantaSing Group Limited American Depositary Shares (QSG) | 210.41% |
Junee Limited Ordinary Shares (JUNE) | 189.86% |
DBV Technologies (DBVT) | 185.41% |
Cantor Equity Partners, Inc Class A Ordinary Shares (CEP) | 182% |
Neuronetics (STIM) | 172.73% |
TMC the metals (TMC) | 171.05% |
Rapid Micro Biosystems (RPID) | 151.65% |
Kindly MD, Inc Common Stock (KDLY) | 146.77% |
VivoPower International (VVPR) | 145.93% |
